POLARIS INSIGHTS

Pfizer Is Down 34% Over the Last 5 Years. Here's Why Its 6% Dividend Yield Might Finally Be Worth the Risk

Key PointsPfizer has faced the challenges of declining coronavirus portfolio revenue and patent expirations in recent years.